arrow
T

Tae-Bum Kim

University of Ulsan College of Medicine
H指数:38
被引数:5,370

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stool and Airway Microbiome Signatures Associated With Treatment Response to Dupilumab in Severe Asthma: Findings From the PRISM Study

严重哮喘患者对Dupilumab治疗反应相关的粪便和气道微生物组特征:PRISM研究的结果

2026-09-230
PRE
Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe Asthma

哮喘持续时间较长与重症哮喘中升高的非T2痰生物标志物和降低的T2炎症相关

2026-07-280
OAAI
Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model

1-甲基烟酰胺循环水平预测Dupilumab对成人哮喘的疗效:一项预测模型

2026-05-060
PRE
Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma
2025-12-010
PRE
Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study
2025-11-011
PRE
Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma

血清和尿液中嗜酸性粒细胞衍生神经毒素(EDN)水平可预测重度哮喘的生物制剂治疗反应

2025-01-010
PRE
Effect of biologic therapies on quality of life in severe asthma Findings from the PRISM study
2024-09-010
OAAI
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents

来自四大洲的严重哮喘队列 (SARP,u-biopred,ProAR和COREA) 中哮喘表型的比较

2024-01-011
OAAI
Clinical Characteristics of T2-Low and T2-High Asthma-Chronic Obstructive Pulmonary Disease Overlap: Findings From COREA Cohort
2024-01-010
OAAI